Search for: "United States v. AT&T, Inc." Results 6641 - 6660 of 8,841
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Mar 2023, 11:54 am by Rebecca Tushnet
Ah, how I wish courts would apply the same scrutiny to trademark harm stories.FedEx Ground Package System, Inc. v. [read post]
16 Mar 2016, 6:43 am by Joy Waltemath
The Geo Group, Inc. dba Arizona State Prison-Florence West and Central Arizona Correctional Facility, March 14, 2016, Callahan, C.). [read post]
6 Dec 2021, 5:30 am by Josh Blackman
Corizon, Inc., 949 F.3d 489, 506 (9th Cir. 2020) (Bumatay, J., dissenting from denial of rehearing en banc) (same); United States v. [read post]
29 Apr 2011, 5:26 am by Susan Brenner
Perverted Justice Foundation, Inc., 2011 WL 1260224 (U.S. [read post]
11 Nov 2013, 1:10 pm by Brian Price
United States, 404 F.3d 744, 750 (3d Cir. 2005), and dismissal is appropriate only if, accepting all of the facts alleged in the complaint as true, the plaintiff has failed to plead “enough facts to state a claim to relief that is plausible on its face,” Bell Atlantic Corp. v. [read post]
20 Oct 2020, 2:06 pm by Phil Dixon
“[T]he Government cannot justify the constitutionality of this traffic stop by relying on a regulatory scheme that was not the basis for the stop. [read post]
1 Apr 2021, 8:33 am by Eugene Volokh
Nationalist Movement, 505 U.S. 123, 134-35 (1992); Hustler Magazine, Inc. v. [read post]
1 Oct 2016, 6:04 pm by Ad Law Defense
Homeopathic medicine was heralded upon its entry into the United States in 1835, primarily because –unlike traditional medicine of the time – it didn’t kill patients (like mercury tinctures) and wasn’t gross (like leaching). [read post]
4 Aug 2010, 9:53 am by Rebecca Tushnet
Before coming to the FTC, Lesley clerked for United States District Judge Fred Shannon in the Western District of Texas, served as a staff counsel to the United States Court of Appeals for the Fifth Circuit, and was a fellow at Georgetown’s Appellate Litigation Clinical Program,. [read post]
12 Nov 2009, 6:33 am
” Pfizer Inc. has announced it will close its $300 million R&D headquarters in New London, Connecticut. [read post]